{
    "clinical_study": {
        "@rank": "119326", 
        "arm_group": [
            {
                "arm_group_label": "Starter infant formula with pro and prebiotics", 
                "arm_group_type": "Active Comparator", 
                "description": "starter infant formula from enrollment till 6 months of age, followed by a commercially available Nestl\u00e9 follow-up formula from 6 to 12 months of age"
            }, 
            {
                "arm_group_label": "starter infant formula without pro and prebiotics", 
                "arm_group_type": "Placebo Comparator", 
                "description": "starter infant formula from enrollment till 6 months of age, followed by a commercially available Nestl\u00e9 follow-up formula from 6 to 12 months of age"
            }, 
            {
                "arm_group_label": "Breastfeeding group", 
                "arm_group_type": "No Intervention", 
                "description": "exclusively breastfeeding during the first 3 months of age, followed by a commercially available Nestl\u00e9 starter infant formula from 4 to 6 months of age (if applicable) and the follow-up infant formula from 6 to 12 months of age"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this trial is to test the efficacy of an infant formula containing synbiotics on\n      the prevention of gastro-intestinal infections."
        }, 
        "brief_title": "Effect of Starter Formula on Infection Prevention", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Gastro-intestinal Infections", 
            "Infections With Fever"
        ], 
        "condition_browse": {
            "mesh_term": "Fever"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy newborn infant\n\n          -  Full term infant (\u2265 37 weeks gestation; \u2264 42 weeks gestation)\n\n          -  Age of infant is \u2264 13 days at the time of enrollment\n\n          -  Birth weight \u2265 2500g and \u2264 4500g\n\n          -  For the FF groups: The infant's mother has elected not to breastfeed\n\n          -  For the BF group: The infant's mother has elected to fully breastfeed her baby, from\n             enrollment to at least 3 months of age\n\n          -  Having obtained his/her legal representative's informed consent\n\n        Exclusion Criteria:\n\n          -  Congenital illness or malformation that may affect normal growth (especially\n             immunodeficiencies)\n\n          -  Significant pre-natal and/or post-natal diseases\n\n          -  Perinatal antibiotic or infants on antibiotics at the time of inclusion\n\n          -  Infants whose mother has had an acute infection during the last month of pregnancy\n\n          -  Re-hospitalisation for more than 2 days in the first 14 days of life (exceptionally,\n             infants re-hospitalized because of jaundice may be enrolled in the study)\n\n          -  Receiving infant formula containing probiotics and/or prebiotics at the time of\n             enrollment\n\n          -  Newborn whose parents / caregivers cannot be expected to comply with treatment\n\n          -  Newborn currently participating in another interventional clinical trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "12 Months", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "477", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01880970", 
            "org_study_id": "07.20.INF"
        }, 
        "intervention": {
            "arm_group_label": "Starter infant formula with pro and prebiotics", 
            "intervention_name": "starter infant formula with pro and prebiotics", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 17, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69317"
                    }, 
                    "name": "H\u00f4pital de la Croix Rousse, Service de r\u00e9animation n\u00e9onatale"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "H\u00f4pital Arnaud de Villeneuve, Service de p\u00e9diatrie 2"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nancy", 
                        "country": "France", 
                        "zip": "54042"
                    }, 
                    "name": "Maternit\u00e9 r\u00e9gionale de Nancy, Service de N\u00e9onatologie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Charit\u00e9 Campus Virchow-Klinikum, Klinik f\u00fcr Geburtsmedizin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Giessen", 
                        "country": "Germany", 
                        "zip": "35392"
                    }, 
                    "name": "Universit\u00e4tsklinikum Gie\u00dfen und Marburg, Zentrum f\u00fcr Kinderheilkunde und Jugendmedizin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Potsdam", 
                        "country": "Germany", 
                        "zip": "14467"
                    }, 
                    "name": "Klinikum Ernest von Bergmann, Klinik f\u00fcr Kinder- und Jugendmedizin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1007 MB"
                    }, 
                    "name": "Vrije Universiteit Medisch Centrum, Afdeling Kindergeneeskunde"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "Netherlands"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "Effect of Starter Formula With Synbiotics on Prevention of Gastro-intestinal Infections and All Infections With Fever in Full Term Infants", 
        "overall_official": {
            "affiliation": "Maternit\u00e9 r\u00e9gionale de Nancy", 
            "last_name": "Jean Michel Hascoet, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "France: Committee for the Protection of Personnes", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "Germany: Ethics Commission", 
                "Netherlands: Medical Ethics Review Committee (METC)"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Mean event rate of diarrhea and all infections with fever per child over 6 months and 1 year", 
            "measure": "Diarrhea and all infections with fever", 
            "safety_issue": "No", 
            "time_frame": "over 6 months and 1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01880970"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Frequency of episodes of morbidity (adverse events), especially mean event rate of respiratory illnesses per child over 6 months and 1 year", 
                "measure": "Morbidity", 
                "safety_issue": "Yes", 
                "time_frame": "over 6 months and 1 year"
            }, 
            {
                "description": "Anthropometry (weight (kg), length (cm), head circumference (cm) and skin fold)", 
                "measure": "Anthropometry", 
                "safety_issue": "No", 
                "time_frame": "until 1 year"
            }, 
            {
                "description": "Digestive tolerance (stool characteristics and frequency, vomiting, regurgitation, frequency of colic)", 
                "measure": "Digestive tolerance", 
                "safety_issue": "No", 
                "time_frame": "until 1 year"
            }, 
            {
                "description": "Stool bacterial populations (Bifidobacteria, Lactobacilli Species, Clostridium, Bacteroides, Staphylococci epidermitis, presence or absence of B. lactis)\nStool pH\nStool and saliva S.IgA\nStool Alpha 1-antitrypsine as infection/inflammation marker", 
                "measure": "Stool characteristics", 
                "safety_issue": "No", 
                "time_frame": "at 3 and 6 months"
            }
        ], 
        "source": "Nestl\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nestl\u00e9", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}